|
|  |
Washington University in St. Louis News & Information > Faculty Experts at Washington University in St. Louis >
Assistant Professor of Economics
Expertise: pricing, infertility, industrial organization, marketing, econometrics
Bio: Professor McManus studies industrial organization and economics. His research interests include industrial organization, empirical economics and theoretical economics. Some of his work has focused on the economics and pricing of infertility treatment in the United States. Prior to joining the Olin School of Business, McManus was an instructor during his graduate studies at the University of Virginia. Before he entered graduate school, he worked as a business systems analyst at American Management Systems.
WUSTL Contact Information:
Education:
-
Ph.D. at University of Virginia
-
M.A. in economics at University of Virginia
-
B.A. in economics and government at College of William and Mary
| News Stories & Tip Sheets: |
Showing 2 Stories.
|
|
'Greater price for a greater good?'
eBay auction items affiliated with a cause command higher prices, study shows
Dec. 14,
2006 --
It's long been assumed that people are willing to pay more for an item if they know a portion of the proceeds will go to charity. But do they really? Two professors from the Olin School of Business at Washington University in St. Louis collected data from eBay auctions. They compared prices of items on eBay's regular auction with items auctioned through its "Giving Works" program where sellers choose to donate part of their earnings to a non-profit of their choosing. They found out that buyers are willing to pay a 5 percent premium on average for those items linked to a cause. More...
|
State mandated insurance coverage and market competition have similar impact on making in vitro fertilization affordable
Olin School of Business professors examine the economics of infertility treatments
Oct. 5,
2005 --
In vitro fertilization can cost anywhere from $10,000 - $15,000 for each round of treatments. This means access to assisted reproductive technologies (ART) is generally limited to a relatively small portion of couples that seek it. Several state governments have turned to public policy in an attempt to make access to ART more widely available. But two professors from the Olin School of Business at Washington University in St. Louis find that market competition can be as effective at expanding access as requiring insurance companies to cover infertility treatments. At the same time, competition appears to lower the rate of high-risk births and encourages the use of new technologies.
|
Showing 2 Stories.
|
|
|
| |
|
Email this page
Print ready page